CD19 CAR-T cells injection

DRUG2 trials

Sponsors

Zhejiang University, Zhujiang Hospital

Conditions

Acute Lymphoblastic LeukemiaMyasthenia Gravis

Phase 1

Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of Refractory Myasthenia Gravis

RecruitingNCT05828225

Zhejiang UniversityMyasthenia Gravis

Start: 2023-04-30End: 2026-04-20Target: 9Updated: 2023-04-25

CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study

RecruitingNCT07072494

Zhujiang HospitalAcute Lymphoblastic Leukemia

Start: 2025-07-19End: 2027-08-19Target: 30Updated: 2025-07-18

Related Papers

Deeper remission achievement and longer leukemia-free survival with inati-cel as consolidation therapy in allogeneic transplant-ineligible adolescent and adult patients with B-ALL

Blood2025-11-03